DDInter260 DDInter45
Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used to treat hyperprolactinemic disorders and Parkinsonian Syndrome. Cabergoline possesses potent agonist activity on dopamine D2 receptors.
A phenothiazine derivative that is used as an antipruritic.
Cabergoline {u} (Compound) binds {v} (Gene) CYP3A4
CYP3A4 {u} (Gene) is bound by {v} (Compound) Alimemazine
Cabergoline {u} (Compound) downregulates {v} (Gene) RPIA
RPIA {u} (Gene) is downregulated by {v} (Compound) Alimemazine
Cabergoline {u} (Compound) causes {v} (Side Effect) Insomnia
Insomnia {u} (Side Effect) is caused by {v} (Compound) Alimemazine
Cabergoline {u} (Compound) resembles {v} (Compound) Pergolide
Pergolide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alimemazine
Cabergoline {u} (Compound) binds {v} (Gene) CYP3A4
CYP3A4 {u} (Gene) is bound by {v} (Compound) Orphenadrine
Orphenadrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alimemazine
Cabergoline {u} (Compound) downregulates {v} (Gene) RPIA
RPIA {u} (Gene) is regulated by {v} (Gene) HRH1
HRH1 {u} (Gene) is bound by {v} (Compound) Alimemazine
Cabergoline {u} (Compound) causes {v} (Side Effect) Insomnia
Insomnia {u} (Side Effect) is caused by {v} (Compound) Oxcarbazepine
Oxcarbazepine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alimemazine
Cabergoline {u} (Compound) resembles {v} (Compound) Lisuride
Lisuride {u} (Compound) resembles {v} (Compound) Pergolide
Pergolide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alimemazine
Cabergoline {u} (Compound) resembles {v} (Compound) Pergolide
Pergolide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methdilazine
Methdilazine {u} (Compound) resembles {v} (Compound) Alimemazine
Cabergoline {u} (Compound) downregulates {v} (Gene) RPIA
RPIA {u} (Gene) regulates {v} (Gene) ST3GAL5
ST3GAL5 {u} (Gene) is upregulated by {v} (Compound) Alimemazine
Cabergoline (Compound) binds CYP3A4 (Gene) and CYP3A4 (Gene) is bound by Alimemazine (Compound)
Cabergoline (Compound) downregulates RPIA (Gene) and RPIA (Gene) is downregulated by Alimemazine (Compound)
Cabergoline (Compound) causes Insomnia (Side Effect) and Insomnia (Side Effect) is caused by Alimemazine (Compound)
Cabergoline (Compound) resembles Pergolide (Compound) and Pergolide may cause a moderate interaction that could exacerbate diseases when taken with Alimemazine
Cabergoline (Compound) binds CYP3A4 (Gene) and CYP3A4 (Gene) is bound by Orphenadrine (Compound) and Orphenadrine may cause a moderate interaction that could exacerbate diseases when taken with Alimemazine
Cabergoline (Compound) downregulates RPIA (Gene) and RPIA (Gene) is regulated by HRH1 (Gene) and HRH1 (Gene) is bound by Alimemazine (Compound)
Cabergoline (Compound) causes Insomnia (Side Effect) and Insomnia (Side Effect) is caused by Oxcarbazepine (Compound) and Oxcarbazepine may cause a moderate interaction that could exacerbate diseases when taken with Alimemazine
Cabergoline (Compound) resembles Lisuride (Compound) and Lisuride (Compound) resembles Pergolide (Compound) and Pergolide may cause a moderate interaction that could exacerbate diseases when taken with Alimemazine
Cabergoline (Compound) resembles Pergolide (Compound) and Pergolide may cause a moderate interaction that could exacerbate diseases when taken with Methdilazine and Methdilazine (Compound) resembles Alimemazine (Compound)
Cabergoline (Compound) downregulates RPIA (Gene) and RPIA (Gene) regulates ST3GAL5 (Gene) and ST3GAL5 (Gene) is upregulated by Alimemazine (Compound)